Dec 23
Regulators have authorized an antiviral drug from Merck known as molnupiravir that may help blunt the wave of infections driven by the omicron variant.
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.
Post a Comment